医学
耐受性
安慰剂
销售授权
不利影响
药品
临床试验
观察研究
随机对照试验
重症监护医学
药理学
内科学
替代医学
生物信息学
生物
病理
作者
Ion Fulga,Olivera Lupescu,Tiberiu Spircu
出处
期刊:PubMed
日期:2012-12-01
卷期号:54 (1 Suppl 4): 23-33
被引量:2
摘要
The results of the current post-authorization study confirm beneficial pain intensity reducing efficacy of Ketospray 10% associated with good local tolerability of 7 days treatment course. Concomitant administration of systemic pain relieving medication did not substantially contribute neither to the relief of pain at rest nor of pain on movement among the subjects of respective study populations.
科研通智能强力驱动
Strongly Powered by AbleSci AI